Resource Center
Resource Center
A CHAI-supported study published in AIDS describes pilot programs in Malawi and Zimbabwe to integrate TB and HIV testing on the same near-point-of-care devices within facilities.
Read more
We are deeply saddened to share the news of the passing of our Board Chair, Dr. Tachi Yamada.
Read more
CHAI and partners' study published in the journal of HIV Medicine looks at whether clients were less likely to keep to their appointment schedules under the Eswatini treat all policy.
Read more
New approaches to ending vertical transmission of hepatitis B overlap with HIV reduction strategies.
Read more
CHAI supported an analysis, published in Clinical Infectious Diseases, identifying readily available, generic HepC treatments that have been successfully used as second-line therapy for patients in Egypt, Georgia, and Myanmar.
Read more
Unitaid and the Clinton Health Access Initiative, Inc. (CHAI) announce pricing agreement with pharmaceutical company Hetero Labs LTD to make available generic version of best-in-class second-line therapy for people living with HIV.
Read more
A full list of sessions that CHAI is participating in at the Internationl AIDS Society conference.
Read more
CHAI presents cost-effectiveness modeling framework at IAS 2021 to understand the role of multipurpose prevention technologies in HIV prevention and family planning.
Read more
Our monthly check-in with staff from around the world. Learn more about the people who work at CHAI.
Read moreThrough this MOU, GARDP, CHAI and Shionogi will use their collective expertise to increase access to cefiderocol in low- and middle-income countries.
Read more